Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C014024 |
2,4,5,2',4',5'-hexachlorobiphenyl |
[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of GLS2 mRNA | affects cotreatment|decreases expression | 16984957
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GLS2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GLS2 mRNA | affects expression | 21346803
|
C019499 |
2-nitrofluorene |
2-nitrofluorene results in decreased expression of GLS2 mRNA | decreases expression | 14600272
|
C023035 |
3,4,5,3',4'-pentachlorobiphenyl |
[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of GLS2 mRNA | affects cotreatment|decreases expression | 16984957
|
C023035 |
3,4,5,3',4'-pentachlorobiphenyl |
3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GLS2 mRNA | decreases expression | 16984957
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of GLS2 mRNA | decreases expression | 14600272
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of GLS2 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of GLS2 protein | affects expression | 20106945
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GLS2 mRNA | affects cotreatment|decreases expression | 18164116
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of GLS2 mRNA | increases expression | 20106945
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of GLS2 mRNA | increases expression | 17720352
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of GLS2 mRNA | affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of GLS2 mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GLS2 mRNA | affects cotreatment|decreases expression | 18164116
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in decreased expression of GLS2 mRNA | decreases expression | 14600272
|
D004958 |
Estradiol |
Estradiol results in decreased expression of GLS2 mRNA | decreases expression | 20106945
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of GLS2 mRNA | decreases expression | 18035473
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid affects the expression of GLS2 mRNA | affects expression | 18281256
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GLS2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of GLS2 mRNA | decreases expression | 17164430
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GLS2 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GLS2 mRNA | decreases expression | 18796159 16054898 16984957
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of GLS2 mRNA | decreases expression | 19559774
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.74 | 11752688 15322242 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.01 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.98 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
6.98 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.98 | 11473722 |
MESH:D000236 |
Adenoma |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
20.38 | 16176798 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
20.38 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
20.38 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
20.38 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
20.38 | 19555203 |
MESH:D018248 |
Adenoma, Liver Cell |
|
3,4,5,3',4'-pentachlorobiphenyl |
24.03 | 16628245 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
24.03 | 17620307 17162532 19052882 16434500 19061943 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
24.03 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
24.03 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.85 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.74 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.96 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.43 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.43 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.69 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
2.92 | 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.92 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
2.92 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.92 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.92 | 12948864 17018787 17289903 16675129 18497071 19861407 17261762 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.92 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.35 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
8.06 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.06 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
11.16 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
11.16 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.16 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
11.16 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.16 | 18691550 20727157 19335982 20214788 21159647 16935385 10672840 18210153 19418558 16878318 20512989 18393292 17428255 19052882 18971187 17055752 19822196 19919837 16681979 16569478 18494052 16328049 19383236 16502159 20514400 19539802 16807293 19701751 3581430 19208518 20084675 18788625 19519916 3084413 18665156 17138121 16779866 16288022 10737359 17761372 19107877 17978847 18056438 19171122 16830150 18506893 11831363 20524982 20101231 20007298 20935162 17173139 17162532 18785209 16540662 20432363 19394651 16698587 18978308 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.16 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.70 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
4.70 | 16033868 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.31 | 18670907 16120746 18850075 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.52 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
20.30 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
20.30 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
20.30 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
20.30 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
20.30 | 19559774 |
MESH:D018281 |
Cholangiocarcinoma |
|
3,4,5,3',4'-pentachlorobiphenyl |
15.67 | 16628245 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
15.67 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
15.67 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.49 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.49 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.06 | 12621046 15340226 16354765 8697196 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
3,4,5,3',4'-pentachlorobiphenyl |
2.89 | 17686920 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.89 | 20055451 10048152 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.53 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.53 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.13 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.13 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.32 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
14.84 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
14.84 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
14.84 | 11529661 18713872 12540782 12958197 2444490 16781746 12153990 11834606 10774834 16177239 16485898 15968718 14550746 16109766 17562736 19085960 19370779 10915739 12594235 16081117 19923254 14986274 16393943 17906064 10663392 14725611 19164858 11739529 12392966 11461765 11421492 11743745 15619225 16227642 19420014 11287661 17522070 19739265 12705907 18071297 19416960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
14.84 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
14.84 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
14.84 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.99 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.68 | 11462148 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
10.87 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.87 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.87 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
3,4,5,3',4'-pentachlorobiphenyl |
12.07 | 17686920 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.07 | 15322242 18230668 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.91 | 18566989 19148513 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.01 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.56 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
4.56 | 17016578 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.46 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
12.46 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.46 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.12 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.12 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.57 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.11 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
3,4,5,3',4'-pentachlorobiphenyl |
10.93 | 17686920 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.93 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.93 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.47 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.31 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
13.83 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.83 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.83 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.93 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.65 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 15340226 16354765 8697196 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.57 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.57 | 12083418 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.08 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.81 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.81 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.52 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
11.52 | 17296493 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
11.52 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.52 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.96 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.96 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.23 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.34 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.61 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.61 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.61 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
16.99 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
16.99 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
16.99 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
16.99 | 15610895 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.12 | 8812269 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.76 | 20032147 19638242 18522880 18407596 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
4.84 | 15161499 16169303 15842777 15504291 12925901 16627068 15366600 18567088 15298665 17724770 15339415 15383259 16270385 18239293 15798949 16009107 15733078 15793283 17640959 14643895 18371158 14568256 12918455 17534399 14709902 15723089 18210741 15081153 15479170 15591649 17196135 17198567 17465448 18364076 17036385 15571005 15099470 16603200 15942678 15744066 16042886 15577212 18095165 14726149 15763062 16570917 15492853 17201889 17719030 18637143 17666798 18629640 15138612 17203207 17881167 15369754 15864749 14659978 15086199 17432682 15067225 18672772 17348192 18237412 16544323 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.84 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.84 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.84 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.81 | 12969438 11587558 19784758 12587719 19460945 16611625 16610002 19014921 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.81 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.35 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
9.35 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
47.21 | 16835634 18644402 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
47.21 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
2-nitrofluorene |
47.21 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
47.21 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
47.21 | 15890375 9163691 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
47.21 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
47.21 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
47.21 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
47.21 | 15175105 20583210 19294768 19255062 18644402 21047994 19426721 19427195 18977376 19551842 18754104 9163691 19690152 20492335 18648771 20405173 20101389 2862719 19254457 19833225 19812893 2422723 20137499 10737359 21278145 20501860 16942905 19642983 12112319 18978307 20452335 20434301 19499222 19850985 19638242 15885732 12771043 19996281 21167192 19256749 19073162 20118626 21071580 19090486 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
47.21 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
47.21 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
47.21 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
47.21 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
22.49 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
22.49 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
22.49 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
22.49 | 18093689 18775883 17942915 16267830 17854601 19539802 19519916 19009564 9362446 18079962 2563599 19126423 18308698 18544905 19004024 17174075 3124819 18164116 18253720 18282651 21159647 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
22.49 | 6150874 1848544 15603536 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
22.49 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
8.39 | 16061637 12438228 9255578 19931552 17139156 18508827 15172992 15893417 16401635 14755239 18813816 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.39 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.39 | 18816296 20869020 20464547 20064080 18569708 18520028 20135361 17053015 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.39 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
8.39 | 16061637 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.39 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.49 | 11807958 16891317 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.38 | 19453300 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.46 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.68 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.10 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.40 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.10 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.93 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.97 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.97 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.98 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.98 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.52 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
8.05 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.05 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.05 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.62 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.34 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.19 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.11 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.11 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.88 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.88 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.01 | 20387270 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.84 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.79 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.56 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.56 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.19 | 19401270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.30 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
5.48 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.48 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.63 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.63 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
9.31 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.31 | 11118676 11896295 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.78 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.14 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.14 | 16740699 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.19 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.33 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.62 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.62 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.30 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.30 | 16192470 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
5.16 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.36 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.36 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
3.36 | 16033868 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
2.90 | 7505956 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.58 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
11.62 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.62 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.62 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
11.62 | 15537745 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.63 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.63 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.87 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.88 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.34 | 17120751 |